Clasificación en acciones
#41229
GENinCode Plc specializes in the creation and commercialization of advanced... GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Precio por acción
$0.01206398
Capitalización bursátil
$33.74K
Comercio GENinCode plc (GENI)
Ingresos de GENinCode plc (GENI)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de GENinCode plc, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de GENinCode plc desde 2026 hasta 2026
Ingresos al final de cada año
| Año |
Ingresos |
Cambiar |
|
Not enough data for the provided dates. |
Ingresos de empresas similares o competidoras
| Empresa |
Ingresos |
Diferencia de ingresos |
País |
|
|
$46.34B |
-
|
US
|
|
|
$25.11B |
-
|
US
|
|
|
- |
-
|
CN
|
|
|
$4.55B |
-
|
US
|
|
|
$2.71B |
-
|
US
|
